Peahl Alex F, Keer Emma, Hallway Alexander, Kenney Brooke, Waljee Jennifer F, Townsel Courtney
Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan.
Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan.
Am J Perinatol. 2024 May;41(S 01):e1459-e1462. doi: 10.1055/s-0043-1767816. Epub 2023 Apr 10.
This study aimed to describe opioid prescribing patterns for pregnant patients with a history of or active opioid use to inform postpartum pain management strategies.
We conducted a retrospective cohort analysis of all patients with a history of opioid use disorder (OUD) or chronic pain seen at a single outpatient clinic specializing in opioid use and OUD in pregnancy from January 2019 to August 2021. Patient characteristics, delivery outcomes, and opioid prescribing information were collected through electronic health record fields. We used descriptive statistics to characterize differences in receipt of an opioid prescription, prescription size, and receipt of a prescription refill across three patient groups: patients with OUD on medication, patients with OUD maintaining abstinence, and patients with chronic pain using opioids. In the study period, the institutional average rate of opioid prescribing after cesarean and vaginal birth were 80.0 and 2.8%, respectively.
Of the 69 patients included in this study, 46 (66.7%) had a history of OUD on medication, 14 (20.3%) had a history of OUD maintaining abstinence, and 9 (13.0%) had a history of chronic pain. Receipt of an opioid prescription after childbirth was more common after cesarean birth (12/23, 52.2%) than vaginal birth (3/46, 6.5%). Refills were common in patients who received an opioid proscription (cesarean: 5/12, 41.7%; vaginal: 1/3, 33.3%).
Compared with institutional averages, postpartum opioid prescribing rates for people with a history of OUD or chronic pain were 50 to 60% lower for cesarean birth and three times higher for vaginal birth. Future work is needed to balance opioid stewardship and harm reduction with adequate pain control in these high-risk populations.
· Opioid prescribing rates for patients with OUD/chronic pain were 60% lower for cesarean birth than institutional averages.. · Opioid prescribing rates for patients with OUD/chronic pain were three times higher for vaginal birth than institutional averages.. · Refill rates following birth were high overall for cesarean (40%) and vaginal (33%) birth.. · More work is needed to balance opioid prescribing with adequate pain control in high-risk patients..
本研究旨在描述有阿片类药物使用史或正在使用阿片类药物的孕妇的阿片类药物处方模式,以为产后疼痛管理策略提供信息。
我们对2019年1月至2021年8月在一家专门诊治孕期阿片类药物使用和阿片类药物使用障碍的门诊诊所就诊的所有有阿片类药物使用障碍(OUD)病史或慢性疼痛的患者进行了回顾性队列分析。通过电子健康记录字段收集患者特征、分娩结局和阿片类药物处方信息。我们使用描述性统计来描述三组患者在接受阿片类药物处方、处方剂量以及处方续配方面的差异:正在接受药物治疗的OUD患者、保持禁欲的OUD患者以及使用阿片类药物的慢性疼痛患者。在研究期间,剖宫产和阴道分娩后机构阿片类药物处方的平均比例分别为80.0%和2.8%。
本研究纳入的69例患者中,46例(66.7%)有正在接受药物治疗的OUD病史,14例(20.3%)有保持禁欲的OUD病史,9例(13.0%)有慢性疼痛病史。剖宫产分娩后接受阿片类药物处方的情况比阴道分娩后更常见(12/23,52.2%对3/46,6.5%)。接受阿片类药物处方的患者中续配情况很常见(剖宫产:5/12,41.7%;阴道分娩:1/3,33.3%)。
与机构平均水平相比,有OUD病史或慢性疼痛的患者剖宫产产后阿片类药物处方率低50%至60%,阴道分娩后则高出三倍。未来需要开展工作,在这些高危人群中平衡阿片类药物管理和减少危害与充分控制疼痛之间的关系。
· 有OUD/慢性疼痛的患者剖宫产阿片类药物处方率比机构平均水平低60%。· 有OUD/慢性疼痛的患者阴道分娩阿片类药物处方率比机构平均水平高两倍。· 剖宫产(40%)和阴道分娩(33%)后总体续配率较高。· 需要开展更多工作以在高危患者中平衡阿片类药物处方与充分控制疼痛之间的关系。